The seroprevalence of hepatitis E virus infection in the preselected population from Romania: a hospital survey by unknown
ORAL PRESENTATION Open Access
The seroprevalence of hepatitis E virus infection
in the preselected population from Romania: a
hospital survey
Valeriu Gheorghiță1,2*, Anca Streinu-Cercel1,3, Oana Săndulescu1,3, Mădălina Popa1, Simona Elena Albu4,
Florin Alexandru Căruntu1,3, Adrian Streinu-Cercel1,3
From The 10th Edition of the Scientific Days of the National Institute for Infectious Diseases “Prof Dr Matei
Bals”
Bucharest, Romania. 15-17 October 2014
Background
Hepatitis E virus (HEV) infection is a significant public
health problem in many parts of the world. The virus is
classified into four major genotypes, representing a single
serotype. HEV genotypes 1 and 2 are restricted to
humans and usually transmitted via fecally-contaminated
water, resulting in large outbreaks and epidemics of acute
hepatitis in developing countries. HEV genotypes 3 and 4
can infect humans as well as other mammalian species
(e.g. pigs) and associate sporadic cases of autochthonous
hepatitis E, recently described in developed countries. In
these areas, zoonotic transmission appears to play a
major role. Moreover, genotype 3 HEV infection can
cause chronic hepatitis in immunosuppressed patients.
The estimated seroprevalence of HEV infection in these
regions is variable, between less than 5% and 52% in
southwestern France. To date, no HEV seroprevalence
studies have been performed in Romania.
Study hypothesis
The specific aim of this observational, cross-sectional
study is to estimate the prevalence of serum anti-HEV
IgG antibodies in the Romanian population. The study
population will include 1000 consecutive patients
admitted in two medical centers from Bucharest over a
period of one year: 900 patients in the National Institute
for Infectious Diseases “Prof. Dr. Matei Balş” and 100
female patients in the Department of Gynecology of the
University Emergency Hospital, Bucharest. The main
inclusion criteria are obtaining the informed consent and
the age over 18 years. Additionally for gynecology, the
female patients must be pregnant. The blood tests will
focus on determination of HEV IgG antibodies using
ELISA tests. Each sample must be accompanied by an
additional questionnaire completed by the patient.
Expected results
Being a country with many patients living in rural areas
with predominantly agricultural occupation, we antici-
pate finding a variable rate of HEV seroprevalence
according to different parameters: age, daily activity (e.g.
pig farmer), rural area residency.
Conclusion
The discovery of autochthonous cases of hepatitis E in
developed countries has substantially changed our under-
standing of HEV infection. As part of the European
Union and considering the data already reported by
many European countries, we need to determine the
HEV IgG seroprevalence in our country, in order to be
able to develop, if necessary, certain public health policies
for decreasing both the human HEV transmission and
the morbidity related to HEV infection.
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